Search Results

Pixium Vision announces the conversion of the safeguard proceedings into receivership

Pixium Vision SA announces the conversion of the safeguard proceedings which has been in place since October 9, 2023 into receivership.

November 13, 2023

·

2 min read

Deals

Pixium Vision announces the launch of a process to find buyers

Pixium Vision SA announces that a tender process for the purpose of finding buyers to acquire the Company’s business will be published tomorrow.

October 18, 2023

·

3 min read

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD

Pixium Vision SA announces data from a first in human trial to assess the efficacy and safety of the PRIMA photovoltaic retinal stimulation microchip for improving visual acuity 48 months post implantation in patients with severe central vision impairment due to dry age-related macular degeneration

November 14, 2023

·

5 min read

Pixium Vision announces its financial results for H1 2023 and provides update

Pixium Vision SA, a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces its financial results for the first half of 2023.

October 26, 2023

·

8 min read

Pixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023

Pixium Vision SA announces that it will hold its annual meeting of shareholders at 14:00 CET on June 13, 2023 at Pixium Vision’s headquarter office.

May 10, 2023

·

1 min read

Biotech Bay

Science Corporation Acquires Pixium’s PRIMA Retinal Implant, Extending and Diversifying Its Commitment to Vision Restoration Through Brain-Computer Interface Technology

Science Corporation has acquired the IP and related assets for the PRIMA retinal implant.

April 25, 2024